Diabetes Research
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
The main purpose of this study is to investigate the effects of switching from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy to tirzepatide glucose-dependent insulinotropic polypeptide/(GIP/GLP-1 RA agonist) in participants with type 2 diabetes (T2D).
Have Type 2 diabetes
Must be overweight
Not be taking diabetes medications 3 months before entering the study
Have Type 1 diabetes
Have history of diabetic eye diseases
Have heart disease or stroke
Have had an episode of ketoacidosis
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.